The Effect of Bright Light Treatment on Rest-Activity Rhythms in People with Dementia: A 24-Week Cluster Randomized Controlled Trial

被引:5
|
作者
Kolberg, Eirin [1 ]
Pallesen, Stale [2 ,3 ,4 ]
Hjetland, Gunnhild Johnsen [1 ,5 ]
Nordhus, Inger Hilde [1 ,6 ]
Flo-Groeneboom, Elisabeth [1 ]
机构
[1] Univ Bergen UiB, Fac Psychol, Dept Clin Psychol, N-5009 Bergen, Norway
[2] Univ Bergen UiB, Fac Psychol, Dept Psychosocial Sci, N-5015 Bergen, Norway
[3] Haukeland Hosp, Norwegian Competence Ctr Sleep Disorders, N-5021 Bergen, Norway
[4] North West Univ, Optentia, Vaal Triangle Campus, ZA-1911 Vanderbijlpark, South Africa
[5] City Dept Hlth & Care, N-5007 Bergen, Norway
[6] Univ Oslo UiO, Fac Med, Dept Behav Med, N-0372 Oslo, Norway
来源
CLOCKS & SLEEP | 2021年 / 3卷 / 03期
关键词
dementia; nursing homes; bright light therapy; rest-activity rhythms; actigraphy; circadian rhythms; clinical trial; CIRCADIAN ACTIVITY RHYTHMS; NURSING-HOME RESIDENTS; MINI-MENTAL-STATE; ALZHEIMERS-DISEASE; INSTITUTIONALIZED PATIENTS; MELATONIN SECRETION; SLEEP; EXPOSURE; DISTURBANCES; INTERVENTION;
D O I
10.3390/clockssleep3030032
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Bright light treatment is an effective way to influence circadian rhythms in healthy adults, but previous research with dementia patients has yielded mixed results. The present study presents a primary outcome of the DEM.LIGHT trial, a 24-week randomized controlled trial conducted at nursing homes in Bergen, Norway, investigating the effects of a bright light intervention. The intervention consisted of ceiling-mounted LED panels providing varying illuminance and correlated color temperature throughout the day, with a peak of 1000 lx, 6000 K between 10 a.m. and 3 p.m. Activity was recorded using actigraphs at baseline and after 8, 16, and 24 weeks. Non-parametric indicators and extended cosine models were used to investigate rest-activity rhythms, and outcomes were analyzed with multi-level regression models. Sixty-one patients with severe dementia (median MMSE = 4) were included. After 16 weeks, the acrophase was advanced from baseline in the intervention group compared to the control group (B = -1.02, 95%; CI = -2.00, -0.05). There was no significant difference between the groups on any other rest-activity measures. When comparing parametric and non-parametric indicators of rest-activity rhythms, 25 out of 35 comparisons were significantly correlated. The present results indicate that ambient bright light treatment did not improve rest-activity rhythms for people with dementia.
引用
收藏
页码:449 / 464
页数:16
相关论文
共 50 条
  • [31] PerCEN: a cluster randomized controlled trial of person-centered residential care and environment for people with dementia
    Chenoweth, Lynn
    Forbes, Ian
    Fleming, Richard
    King, Madeleine T.
    Stein-Parbury, Jane
    Luscombe, Georgina
    Kenny, Patricia
    Jeon, Yun-Hee
    Haas, Marion
    Brodaty, Henry
    INTERNATIONAL PSYCHOGERIATRICS, 2014, 26 (07) : 1147 - 1160
  • [32] The effect of bright light therapy on sleep in pregnant women with major depressive disorder- a randomized controlled trial
    Zarchev, Milan
    Bais, Babette
    Meijer, Julia S.
    Bijma, Hilmar H.
    van der Zande, Bianca
    Luik, Annemarie I.
    Lambregtse-van den Berg, Mijke P.
    Kamperman, Astrid M.
    ARCHIVES OF WOMENS MENTAL HEALTH, 2025,
  • [33] Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a 24-week double-blind, randomized, parallel, placebo-controlled trial
    Huerta-Ramos, Elena
    Labad, Javier
    Cobo, Jesus
    Nunez, Christian
    Creus, Marta
    Garcia-Pares, Gemma
    Cuadras, Daniel
    Franco, Jose
    Miquel, Eva
    Reyes, Julio-Cesar
    Marco-Garcia, Silvia
    Rodriguez, Carolina
    Rodriguez, Carolina
    Beneitez, Isabel
    Costa, Joan
    Castro, Lourdes
    Teba, Silvia
    Milian, Laura
    Foix, Alexandrina
    Rivero, Sonia
    Cavero, Marian
    Argemi, Maria
    Teba, Fernando
    Arranz, Belen
    Rubio, Elena
    Coromina, Marta
    Santos, Angeles
    Bogas, Jose Luis
    Barber, Ana
    Romans, Carlota
    Marquez, Manel
    Sabata, Anna
    Nieto, Lourdes
    Willikens, Eva
    Blanch, Enrich
    Acebillo, Siddharta
    Coronas, Ramon
    Ortega, Laura
    Coll, Ignasi
    Valero, Joaquin
    Rodriguez, Jesus
    Perez, Modesto
    Niubo, Ines
    Tost, Montse
    Monfort, Mari Pau
    Martorell, Lourdes
    Vilella, Elisabet
    Usall, Judith
    Huerta-Ramos, Elena
    Labad, Javier
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2020, 270 (06) : 729 - 737
  • [34] Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a 24-week double-blind, randomized, parallel, placebo-controlled trial
    Elena Huerta-Ramos
    Javier Labad
    Jesus Cobo
    Christian Núñez
    Marta Creus
    Gemma García-Parés
    Daniel Cuadras
    José Franco
    Eva Miquel
    Julio-César Reyes
    Silvia Marcó-García
    Judith Usall
    European Archives of Psychiatry and Clinical Neuroscience, 2020, 270 : 729 - 737
  • [35] Circadian rest-activity rhythms during benzodiazepine tapering covered by melatonin versus placebo add-on: data derived from a randomized clinical trial
    Lone Baandrup
    Ole Bernt Fasmer
    Birte Yding Glenthøj
    Poul Jørgen Jennum
    BMC Psychiatry, 16
  • [36] A 4-week morning light treatment with stable sleep timing for individuals with fibromyalgia: a randomized controlled trial
    Burgess, Helen J.
    Bahl, Sonal
    Wilensky, Katelyn
    Spence, Emily
    Jouppi, Riley J.
    Rizvydeen, Muneer
    Goldstein, Cathy
    Kim, Hyungjin Myra
    Williams, David A.
    Burns, John W.
    PAIN MEDICINE, 2023, 24 (07) : 787 - 795
  • [37] Dementia and Physical Activity (DAPA) - an exercise intervention to improve cognition in people with mild to moderate dementia: study protocol for a randomized controlled trial
    Atherton, Nicky
    Bridle, Chris
    Brown, Deborah
    Collins, Helen
    Dosanjh, Sukhdeep
    Griffiths, Frances
    Hennings, Susie
    Khan, Kamran
    Lall, Ranjit
    Lyle, Samantha
    McShane, Rupert
    Mistry, Dipesh
    Nichols, Vivien
    Petrou, Stavros
    Sheehan, Bart
    Slowther, Anne-Marie
    Thorogood, Margaret
    Withers, Emma
    Zeh, Peter
    Lamb, Sarah E.
    TRIALS, 2016, 17
  • [38] Ginkgo biloba extract EGb 761® in dementia:: Intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial
    Konowski, S
    Hoerr, R
    PHARMACOPSYCHIATRY, 2003, 36 (06) : 297 - 303
  • [39] Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: Results from a 24-week, double-blind, placebo-controlled, Randomized trial
    Homma, Akira
    Imai, Yukimichi
    Tago, Hisao
    Asada, Takashi
    Shigeta, Masahiro
    Iwamoto, Toshihiko
    Takita, Masashi
    Arimoto, Itaru
    Koma, Hiroshi
    Ohbayashi, Toshio
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2008, 25 (05) : 399 - 407
  • [40] Adjunctive bright light treatment with gradual advance in unipolar major depressive disorder with evening chronotype - A randomized controlled trial
    Chan, Joey W. Y.
    Lam, S. P.
    Li, Shirley X.
    Chau, Steven W. H.
    Chan, S. Y.
    Chan, N. Y.
    Zhang, J. H.
    Wing, Y. K.
    PSYCHOLOGICAL MEDICINE, 2022, 52 (08) : 1448 - 1457